CD95 (FAS) e CD178 (FASL) induzem apoptose em células CD4+ E CD8+ do sangue periférico e esplênicas em cães naturalmente infectados por Leishmania spp: Kathlenn Liezbeth Oliveira Silva. -

Pós-graduação em Ciência Animal - FMVA

Diagnóstico da leishmaniose visceral canina pelas técnicas de imunoistoquímica e PCR em tecidos cutâneos em associação com a Rifi e Elisa-teste

Pós-graduação em Ciência Animal - FMVA

Frequência de cães sorologicamente reagentes para leptospirose na área territorial urbana do município de Botucatu - SP, e a sua correlação com os fatores predisponentes ambientais de criação

Pós-graduação em Medicina Veterinária - FMVZ

Leishmaniose visceral no município de Barcarena, Pará: importância do comportamento da enzootia canina por Leishmania (Leishmania) chagasi e de outros fatores para a infecção humana

A leishmaniose é uma doença infecciosa não contagiosa de evolução crônica com altos índices de mortalidade, sendo que o Brasil notifica cerca de 90% dos casos do continente Americano. Sua importância no contexto da saúda publica tem aumentado em função do crescente número de casos que vem ocorrendo não só na zona rural como também na periferia de grandes centros urbanos. A epidemiologia do LV no Brasil é baseada na ocorrência de casos clínicos. Neste sentido o presente estudo propôs-se a estudar o comportamento da enzootia como sua importância e de outros fatores para a infecção humana. Pois pouco se conhece sobre os determinantes de infecção e sua importância na manutenção da doença. Para isso foi definido de uma localidade município de Barcarena, onde a população é estável, ocorrendo a doença de forma endêmica. O estudo acompanhou durante um ano duas coortes, sendo uma para caninos, com 172 cães, e uma para humanos, com 1064 pessoas das quais apenas 1012 participaram da coleta de material, pois 52 pessoas estavam fora da faixa de idade compatível para a realização dos procedimentos. A realização do teste sorológico de Reação de Imunofluorescência Indireta (RIFI), teve como finalidade a determinação de prevalência inicial de infecção e as incidências em dois momentos do estudo, tanto da população humana quanto canina. Também foi realizado na população humana a Intradermo Reação de Montenegro (IDRM) com a mesma finalidade, aferir a prevalência e incidência de infecção através deste método. Outros fatores também foram analisados e podem estar associados ao risco para a infecção. A análise estatística dos dados foi realizada com auxilio dos programas EPI INFO versão 6.04 e BIOESTAT versão 3.0 e os testes aplicados foram o Qui - Quadrado e o cálculo de prevalência e incidência. No inquérito sorológico canino foi observado uma prevalência de infecção canina de 37,2% e, a incidência seis meses após, foi de 29,2%. No intervalo da segunda para a terceira coleta foi realizada a eutanásia dos cães sorologicamente positivos, num total de 70 cães, pois 15 haviam morrido antes da intervenção. A incidência calculada após a intervenção mostrou uma taxa de 14,6%, o que caracteriza uma redução de cerca de 50%. Quanto à titulação, em todas as etapas foram observados títulos considerados elevados. Vale ressaltar que dos 54 animais que não apresentavam sinais clínicos, 30 estavam infectados (55,5%). Quando realizado o inquérito sorológico humano, foi observada uma prevalência de infecção humana de 5,25%, e a incidência seis meses após foi de 1,8% e na ultima avaliação 7,0%, com aumento de cerca de 300%. Em relação às características da população foi observado que entre os infectados não houve predomínio de nenhuma faixa etária. A variável sexo não foi significativa para a ocorrência de infecção. Sobre os infectados tanto pela RIFI, quanto a IDRM, destaca-se a significância estatística da variável ocupação, e neste contexto, a categoria agricultor foi a que se apresentou com maior proporção. As variáveis tempo residência no local, proximidade de residência com a mata, destino do lixo e dejetos também mostraram- se significativas. Quanto a variável faixa etária, a distribuição dos infectados pela RIFI não foi predominante em nenhuma faixa; na IDRM, observou-se que à medida que aumenta a idade aumenta também a proporção de infectados. Outros resultados foram observados de grande relevância para a associação ao risco de infecção, mas a observação quanto a infectados pela RIFI e IDRM foi a que mereceu destaque em função da significância estatística. O estudo mostrou-se adequado para o conhecimento da prevalência e incidência de infecção canina e humana na localidade, assim como o comportamento de alguns fatores que associados podem constituir-se em risco para infecção.

Diagnóstico e epidemiologia da Entamoeba histolytica em residentes do município de Juruti-Pará

Amebíase é a infecção no homem causada pelo protozoário Entamoeba histolytica, apresentam quadros sem manifestações clínicas até graves de elevada morbimortalidade e sendo responsável por milhões de casos de disenteria e abscessos hepáticos a cada ano. Os dados epidemiológicos da amebíase no Brasil estão sendo reavaliados desde que a Entamoeba histolytica (patogênica) foi considerada espécie distinta da Entamoeba dispar (não patogênica). Neste estudo, realizou- se o diagnóstico da amebíase por meio de métodos parasitológicos, pesquisa de antígenos e método molecular em amostras fecais de pacientes residentes no município de Juruti, Pará, Brasil. Foram analisadas 188 amostras, com positividade em 28 (14,89 %) no método imunológico, que foi considerado como padrão ouro. A infecção por E. histolytica foi maior no grupo etário acima de 14 anos (8,51%) que no grupo de 0-14 anos (6,38%), porém sem significância estatística (p > 0,05). Houve discordância nos resultados dos métodos ELISA e coproscópico em 41 amostras (21,81%), com maior número de positivos no teste imunoenzimático. O diagnóstico pelo método de PCR apresentou positividade de 5,88% (3/51), resultado inferior ao observado na microscopia (7,84% - 4/51) e teste de ELISA (11,76% - 6/51). Assim, nossos resultados sugerem que a amebíase intestinal é um problema de saúde pública no município de Juruti.

Occurrence of Mycobacterium bovis and non-tuberculous mycobacteria (NTM) in raw and pasteurized milk in the northwestern region of Paraná, Brazil

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Detecção de Salmonella Enteritidis em ovos de codornas japonesas submetidas a dietas com diferentes níveis de cálcio e fósforo

The eggs are pointed in several studies as the main cause of human salmonellosis. Have been identified that eggs are eaten raw or poorly processed are mainly responsible for outbreaks of human infection with Salmonella spp. Besides causing problems to public health, the presence of bacteria impedes or hinders the international food trade, as a sanitary barrier. Several factors predisposing to contamination of the internal contents of eggs for Salmonella spp., including the egg shell quality (shell quality), which is related to levels of calcium (Ca) and phosphorus (P) in the diet of quails . The experiment used eggs of Japanese quail under different diets containing two levels of Ca (2.0 and 3.5%) and two levels of available P (0.25 and 0.45%). Eggs of 120 japanese quails were divided into four treatments with three replicates. The experiment was divided into three production stages: initial, intermediate and final. Were assessed at each stage the presence of bacteria in internal and external content of experimentally contaminated eggs during periods of 0, 24, 96 and 168 hours after immersion in broth containing Salmonella Enteriditis. Salmonella Enteriditis was detected in the shell during all periods of storage, in decreasing amounts in all treatments. None of the treatments within the three production stages analyzed, we detected significant amounts of the bacteria inside the egg, in our experimental conditions. Therefore, the levels of Ca and P in the diets of quail do not determine higher or lower risks to public health represented by eggs

Ocorrência, sorotipagem e rsistência antimicrobiana de Streptococcus suis em funcionários e ambente de abatedouro de sínos

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Crystal structure of Staphylococcus aureus exfoliative toxin D-like protein: structural basis for the high specificity of exfoliative toxins

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Study on Chagas disease occurrence in the municipality of Monte Negro, State of Rondônia, Brazilian Amazon

Introduction: Studies on Chagas disease deal with the perspective of its occurrence in the Amazon region, which is directly correlated to the population growth and the spread of the bug biotope. The state of Rondônia has an immense source of vectors (Triatomine) and reservoirs of Trypanosoma cruzi. Environmental changes brought forth by the deforestation in the region may cause vector behavior changes and bring these vectors to a closer contact with humans, increasing the probability of vector infection. Methods: This study was carried out to check the occurrence of Chagas disease in the municipality of Monte Negro, Rondônia, Brazil, based on a random sampling of the farms and people wherein blood collection from the population and capturing triatomines were done. The blood samples were submitted to serologic tests to detect antibodies of the IgG class against T. cruzi. The triatomines that were collected had their digestive tract checked for the presence of trypanosomatidae with morphology resembling that of the T. cruzi. Results: The population examined was mostly from other states. From the 322 bugs examined on the microscope, 50% showed parasites with morphology compatible with T. cruzi. From the serology of 344 random samples of human blood, 1.2% was found positive, 6% showed inconclusive results, and 92.8% were negative. Conclusions: Monte Negro shows low prevalence of human infection by T. cruzi and none active vector transmission; however, preventive and surveying measures, which are not performed until now, shall be taken due to the abundance of vectors infected by trypanosomatidae.

Tuberculosis

Tuberculosis is a term that encompasses various diseases caused by bacteria of the Mycobacterium tuberculosis complex, including M tuberculosis, M bovis, M africanum, and other mycobacterial species. Whereas M tuberculosis infection is largely spread from human to human, M bovis infection has been identified as a zoonotic disease with most cases of human infection attributable to animal sources. The mycobacteria other than tuberculosis complex (MOTT), which includes M avium subsp avium and M avium subsp intracellulare isolated from animals, has been isolated from immune-compromised humans (ie, those with human immunodeficiency virus [HIV] infection), but seldom from immunocompetent humans. Recently, there has been increased interest among public health officials in drug-resistant strains of M tuberculosis, M bovis, and M avium because several have been isolated from HIV-infected and nonimmuno-compromised humans.

A Preliminary Note on Trichinosis Investigations in Alaska

Trichinosis in the arctic regions of the world has received considerable attention during recent years, particularly since the work of Roth (1948) in Greenland. In Connell's (1949) review of arctic trichinosis some Alaskan and Canadian records were included but, until now, little has been known of the status of the disease in Alaska. Information available at the present time indicates that the incidence of trichinosis is high in circumpolar carnivores and that marine mammals have a definite place in its epizootiology. Present knowledge cannot explain the survival of trichinosis in marine mammal populations, but it is evident that they may serve as important sources of human infection. Up to the present time the following mammals from Alaska have been found to be infected: From the arctic coast-polar bear, Thalarctas maritimus; arctic fox, Alapex lagapus irmuitus; red fox, Vulpes fulva alascemis; white whale, Delphinapterus leucas; Eskimo dog. From south of the Brooks Range--brown and grizzly bears, Ursus spp.; wolf, Canis lupus ssp.; wolverine. Gula l. luscus. At the time of writing, nearly ail species of land carnivores in Alaska have been examined as well as many other mammalian species less likely to be infected, including various rodents, shrews, and others.

Impatto di rifaximina sul microbiota intestinale: selezione di bifidobatteri antibiotico resistenti

The ideal approach for the long term treatment of intestinal disorders, such as inflammatory bowel disease (IBD), is represented by a safe and well tolerated therapy able to reduce mucosal inflammation and maintain homeostasis of the intestinal microbiota. A combined therapy with antimicrobial agents, to reduce antigenic load, and immunomodulators, to ameliorate the dysregulated responses, followed by probiotic supplementation has been proposed. Because of the complementary mechanisms of action of antibiotics and probiotics, a combined therapeutic approach would give advantages in terms of enlargement of the antimicrobial spectrum, due to the barrier effect of probiotic bacteria, and limitation of some side effects of traditional chemiotherapy (i.e. indiscriminate decrease of aggressive and protective intestinal bacteria, altered absorption of nutrient elements, allergic and inflammatory reactions). Rifaximin (4-deoxy-4’-methylpyrido[1’,2’-1,2]imidazo[5,4-c]rifamycin SV) is a product of synthesis experiments designed to modify the parent compound, rifamycin, in order to achieve low gastrointestinal absorption while retaining good antibacterial activity. Both experimental and clinical pharmacology clearly show that this compound is a non systemic antibiotic with a broad spectrum of antibacterial action, covering Gram-positive and Gram-negative organisms, both aerobes and anaerobes. Being virtually non absorbed, its bioavailability within the gastrointestinal tract is rather high with intraluminal and faecal drug concentrations that largely exceed the MIC values observed in vitro against a wide range of pathogenic microorganisms. The gastrointestinal tract represents therefore the primary therapeutic target and gastrointestinal infections the main indication. The little value of rifaximin outside the enteric area minimizes both antimicrobial resistance and systemic adverse events. Fermented dairy products enriched with probiotic bacteria have developed into one of the most successful categories of functional foods. Probiotics are defined as “live microorganisms which, when administered in adequate amounts, confer a health benefit on the host” (FAO/WHO, 2002), and mainly include Lactobacillus and Bifidobacterium species. Probiotic bacteria exert a direct effect on the intestinal microbiota of the host and contribute to organoleptic, rheological and nutritional properties of food. Administration of pharmaceutical probiotic formula has been associated with therapeutic effects in treatment of diarrhoea, constipation, flatulence, enteropathogens colonization, gastroenteritis, hypercholesterolemia, IBD, such as ulcerative colitis (UC), Crohn’s disease, pouchitis and irritable bowel syndrome. Prerequisites for probiotics are to be effective and safe. The characteristics of an effective probiotic for gastrointestinal tract disorders are tolerance to upper gastrointestinal environment (resistance to digestion by enteric or pancreatic enzymes, gastric acid and bile), adhesion on intestinal surface to lengthen the retention time, ability to prevent the adherence, establishment and/or replication of pathogens, production of antimicrobial substances, degradation of toxic catabolites by bacterial detoxifying enzymatic activities, and modulation of the host immune responses. This study was carried out using a validated three-stage fermentative continuous system and it is aimed to investigate the effect of rifaximin on the colonic microbial flora of a healthy individual, in terms of bacterial composition and production of fermentative metabolic end products. Moreover, this is the first study that investigates in vitro the impact of the simultaneous administration of the antibiotic rifaximin and the probiotic B. lactis BI07 on the intestinal microbiota. Bacterial groups of interest were evaluated using culture-based methods and molecular culture-independent techniques (FISH, PCR-DGGE). Metabolic outputs in terms of SCFA profiles were determined by HPLC analysis. Collected data demonstrated that rifaximin as well as antibiotic and probiotic treatment did not change drastically the intestinal microflora, whereas bacteria belonging to Bifidobacterium and Lactobacillus significantly increase over the course of the treatment, suggesting a spontaneous upsurge of rifaximin resistance. These results are in agreement with a previous study, in which it has been demonstrated that rifaximin administration in patients with UC, affects the host with minor variations of the intestinal microflora, and that the microbiota is restored over a wash-out period. In particular, several Bifidobacterium rifaximin resistant mutants could be isolated during the antibiotic treatment, but they disappeared after the antibiotic suspension. Furthermore, bacteria belonging to Atopobium spp. and E. rectale/Clostridium cluster XIVa increased significantly after rifaximin and probiotic treatment. Atopobium genus and E. rectale/Clostridium cluster XIVa are saccharolytic, butyrate-producing bacteria, and for these characteristics they are widely considered health-promoting microorganisms. The absence of major variations in the intestinal microflora of a healthy individual and the significant increase in probiotic and health-promoting bacteria concentrations support the rationale of the administration of rifaximin as efficacious and non-dysbiosis promoting therapy and suggest the efficacy of an antibiotic/probiotic combined treatment in several gut pathologies, such as IBD. To assess the use of an antibiotic/probiotic combination for clinical management of intestinal disorders, genetic, proteomic and physiologic approaches were employed to elucidate molecular mechanisms determining rifaximin resistance in Bifidobacterium, and the expected interactions occurring in the gut between these bacteria and the drug. The ability of an antimicrobial agent to select resistance is a relevant factor that affects its usefulness and may diminish its useful life. Rifaximin resistance phenotype was easily acquired by all bifidobacteria analyzed [type strains of the most representative intestinal bifidobacterial species (B. infantis, B. breve, B. longum, B. adolescentis and B. bifidum) and three bifidobacteria included in a pharmaceutical probiotic preparation (B. lactis BI07, B. breve BBSF and B. longum BL04)] and persisted for more than 400 bacterial generations in the absence of selective pressure. Exclusion of any reversion phenomenon suggested two hypotheses: (i) stable and immobile genetic elements encode resistance; (ii) the drug moiety does not act as an inducer of the resistance phenotype, but enables selection of resistant mutants. Since point mutations in rpoB have been indicated as representing the principal factor determining rifampicin resistance in E. coli and M. tuberculosis, whether a similar mechanism also occurs in Bifidobacterium was verified. The analysis of a 129 bp rpoB core region of several wild-type and resistant bifidobacteria revealed five different types of miss-sense mutations in codons 513, 516, 522 and 529. Position 529 was a novel mutation site, not previously described, and position 522 appeared interesting for both the double point substitutions and the heterogeneous profile of nucleotide changes. The sequence heterogeneity of codon 522 in Bifidobacterium leads to hypothesize an indirect role of its encoded amino acid in the binding with the rifaximin moiety. These results demonstrated the chromosomal nature of rifaximin resistance in Bifidobacterium, minimizing risk factors for horizontal transmission of resistance elements between intestinal microbial species. Further proteomic and physiologic investigations were carried out using B. lactis BI07, component of a pharmaceutical probiotic preparation, as a model strain. The choice of this strain was determined based on the following elements: (i) B. lactis BI07 is able to survive and persist in the gut; (ii) a proteomic overview of this strain has been recently reported. The involvement of metabolic changes associated with rifaximin resistance was investigated by proteomic analysis performed with two-dimensional electrophoresis and mass spectrometry. Comparative proteomic mapping of BI07-wt and BI07-res revealed that most differences in protein expression patterns were genetically encoded rather than induced by antibiotic exposure. In particular, rifaximin resistance phenotype was characterized by increased expression levels of stress proteins. Overexpression of stress proteins was expected, as they represent a common non specific response by bacteria when stimulated by different shock conditions, including exposure to toxic agents like heavy metals, oxidants, acids, bile salts and antibiotics. Also, positive transcription regulators were found to be overexpressed in BI07-res, suggesting that bacteria could activate compensatory mechanisms to assist the transcription process in the presence of RNA polymerase inhibitors. Other differences in expression profiles were related to proteins involved in central metabolism; these modifications suggest metabolic disadvantages of resistant mutants in comparison with sensitive bifidobacteria in the gut environment, without selective pressure, explaining their disappearance from faeces of patients with UC after interruption of antibiotic treatment. The differences observed between BI07-wt e BI07-res proteomic patterns, as well as the high frequency of silent mutations reported for resistant mutants of Bifidobacterium could be the consequences of an increased mutation rate, mechanism which may lead to persistence of resistant bacteria in the population. However, the in vivo disappearance of resistant mutants in absence of selective pressure, allows excluding the upsurge of compensatory mutations without loss of resistance. Furthermore, the proteomic characterization of the resistant phenotype suggests that rifaximin resistance is associated with a reduced bacterial fitness in B. lactis BI07-res, supporting the hypothesis of a biological cost of antibiotic resistance in Bifidobacterium. The hypothesis of rifaximin inactivation by bacterial enzymatic activities was verified by using liquid chromatography coupled with tandem mass spectrometry. Neither chemical modifications nor degradation derivatives of the rifaximin moiety were detected. The exclusion of a biodegradation pattern for the drug was further supported by the quantitative recovery in BI07-res culture fractions of the total rifaximin amount (100 μg/ml) added to the culture medium. To confirm the main role of the mutation on the β chain of RNA polymerase in rifaximin resistance acquisition, transcription activity of crude enzymatic extracts of BI07-res cells was evaluated. Although the inhibition effects of rifaximin on in vitro transcription were definitely higher for BI07-wt than for BI07-res, a partial resistance of the mutated RNA polymerase at rifaximin concentrations > 10 μg/ml was supposed, on the basis of the calculated differences in inhibition percentages between BI07-wt and BI07-res. By considering the resistance of entire BI07-res cells to rifaximin concentrations > 100 μg/ml, supplementary resistance mechanisms may take place in vivo. A barrier for the rifaximin uptake in BI07-res cells was suggested in this study, on the basis of the major portion of the antibiotic found to be bound to the cellular pellet respect to the portion recovered in the cellular lysate. Related to this finding, a resistance mechanism involving changes of membrane permeability was supposed. A previous study supports this hypothesis, demonstrating the involvement of surface properties and permeability in natural resistance to rifampicin in mycobacteria, isolated from cases of human infection, which possessed a rifampicin-susceptible RNA polymerase. To understand the mechanism of membrane barrier, variations in percentage of saturated and unsaturated FAs and their methylation products in BI07-wt and BI07-res membranes were investigated. While saturated FAs confer rigidity to membrane and resistance to stress agents, such as antibiotics, a high level of lipid unsaturation is associated with high fluidity and susceptibility to stresses. Thus, the higher percentage of saturated FAs during the stationary phase of BI07-res could represent a defence mechanism of mutant cells to prevent the antibiotic uptake. Furthermore, the increase of CFAs such as dihydrosterculic acid during the stationary phase of BI07-res suggests that this CFA could be more suitable than its isomer lactobacillic acid to interact with and prevent the penetration of exogenous molecules including rifaximin. Finally, the impact of rifaximin on immune regulatory functions of the gut was evaluated. It has been suggested a potential anti-inflammatory effect of rifaximin, with reduced secretion of IFN-γ in a rodent model of colitis. Analogously, it has been reported a significant decrease in IL-8, MCP-1, MCP-3 e IL-10 levels in patients affected by pouchitis, treated with a combined therapy of rifaximin and ciprofloxacin. Since rifaximin enables in vivo and in vitro selection of Bifidobacterium resistant mutants with high frequency, the immunomodulation activities of rifaximin associated with a B. lactis resistant mutant were also taken into account. Data obtained from PBMC stimulation experiments suggest the following conclusions: (i) rifaximin does not exert any effect on production of IL-1β, IL-6 and IL-10, whereas it weakly stimulates production of TNF-α; (ii) B. lactis appears as a good inducer of IL-1β, IL-6 and TNF-α; (iii) combination of BI07-res and rifaximin exhibits a lower stimulation effect than BI07-res alone, especially for IL-6. These results confirm the potential anti-inflammatory effect of rifaximin, and are in agreement with several studies that report a transient pro-inflammatory response associated with probiotic administration. The understanding of the molecular factors determining rifaximin resistance in the genus Bifidobacterium assumes an applicative significance at pharmaceutical and medical level, as it represents the scientific basis to justify the simultaneous use of the antibiotic rifaximin and probiotic bifidobacteria in the clinical treatment of intestinal disorders.

Epatite E: ruolo del suino nella trasmissione dell'infezione all'uomo, studio di prevalenza in aree rurali della Bolivia

L’infezione da virus dell’ epatite E (HEV) nei suini e nell’uomo è stata segnalata in diversi Paesi. Nei suini, il virus causa infezioni asintomatiche, mentre nell’uomo è responsabile di epidemie di epatite ad andamento acuto nei Paesi a clima tropicale o subtropicale con condizioni igieniche scadenti, di casi sporadici in quelli sviluppati. HEV è stato isolato anche in diversi animali e l’analisi nucleotidica degli isolati virali di origine animale ha mostrato un elevato grado di omologia con i ceppi di HEV umani isolati nelle stesse aree geografiche, avvalorando l’ipotesi che l'infezione da HEV sia una zoonosi. In America del Sud HEV suino è stato isolato per la prima volta in suini argentini nel 2006, mentre solo dal 1998 esistono dati sull’ infezione da HEV nell’uomo in Bolivia. In questa indagine è stato eseguito uno studio di sieroprevalenza in due comunità rurali boliviane e i risultati sono stati confrontati con quelli dello studio di sieroprevalenza sopra menzionato condotto in altre zone rurali della Bolivia. Inoltre, mediante Nested RT-PCR, è stata verificata la presenza di HEV nella popolazione umana e suina. La sieroprevalenza per anticorpi IgG anti-HEV è risultata pari al 6,2%, molto simile a quella evidenziata nello studio precedente. La prevalenza maggiore (24%) si è osservata nei soggetti di età compresa tra 41 e 50 anni, confermando che l’ infezione da HEV è maggiore fra i giovani-adulti. La ricerca di anticorpi anti HEV di classe IgM eseguita su 52 sieri ha fornito 4 risultati positivi. Il genoma virale è stato identificato in uno dei 22 pool di feci umane e l'esame virologico di 30 campioni individuali fecali e 7 individuali di siero ha fornito rispettivamente risultati positivi in 4/30 e 1/7. La Nested RT-PCR eseguita sui 22 pool di feci suine ha dato esito positivo in 7 pool. L’analisi delle sequenze genomiche di tutti gli amplificati ha consentito di stabilire che gli isolati umani appartenevano allo stesso genotipo III di quelli suini e presentavano con questi una elevata omologia aminoacidica (92%).